Volpara Health Technologies (“Volpara,” “the Group,” or “the Company”; ASX:VHT), a global leader in software for the early detection of breast cancer, today announced that it has signed a contract with Radnet Management, Inc. (“RadNet”), for an initial contract period of 42 months, with the mutual option to extend.

RadNet, based in Los Angeles, California, is the largest provider of outpatient imaging services in the United States. RadNet has 9,000 employees and operates across 353 imaging centres in seven states.

The volume-based contract sees RadNet implementing Volpara® Analytics™ and Volpara® Risk Pathways™ software throughout its organisation. Volpara Analytics’s artificial intelligence will consistently manage mammography quality across RadNet’s 350+ sites. Volpara Risk Pathways provides risk-based screening to ensure RadNet patients have access to essential imaging and genetic testing. Planning for the implementation has begun, with go-live projected in 2023. Management expects that revenue generated under the agreement will be material to the Company.

Volpara Group CEO Teri Thomas said: “Volpara is pleased to partner with such a large and wellrespected organisation as RadNet. Together we will save even more families from cancer. This is a broader partnership than a simple software purchase. We look forward to a deep engagement with RadNet as part of our focus on industry impacts and customer success of ‘elephant-sized’ industry leaders.”

Source: https://www.volparahealth.com/